Use of immune checkpoint inhibitors for cancer was associated with a significant reduction in actinic keratoses in a small study. The effect was greatest in younger patients and those with a history ...

The most robust evidence to date shows that people with a type of lung cancer lived longer if they received immunotherapy before 3pm ...

Cancer immunotherapy has transformed modern oncology by harnessing body's own immune system to combat malignant disease.

Please provide your email address to receive an email when new articles are posted on . Treatment with any immune checkpoint inhibitor increased venous thromboembolism risk for adults with metastatic ...

Three years after enrolling its first patients, a consortium of researchers examining the growing issue of immune-related adverse events due to immune checkpoint inhibitor cancer therapy released a ...

A key molecular mechanism drives the growth of liver cell cancer while simultaneously suppressing the body's immune response ...

New research has uncovered immune changes in cancer patients that could help identify which patients are most at risk of dangerous heart complications from cancer drugs, known as immune checkpoint ...

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA (nogapendekin alfa inbakicept) clinical program in non-small cell lung ...

The emerging cancer therapy market, driven by breakthroughs like CAR-T cells and checkpoint inhibitors, offers significant growth opportunities. Companies advancing these technologies stand to benefit ...

Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research ...

Investigators analyzed economic evaluations of adjuvant immunotherapy to assess cost-effectiveness outcomes, quality-adjusted life-year (QALY)/life-year (LY) gains, and methodologic approaches.